LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Home・Akciju saraksts・CareDx Inc

CareDx Inc

Slēgts

SektorsVeselības aprūpe

17.06 -2.63

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

16.94

Max

17.22

Galvenie mērījumi
By Trading Economics
Ienākumi	-5.8M -4.1M
Pārdošana	8.3M 108M
P/E Sektora vidējais	14.645 57.833
EPS	0.12
Peļņas marža	-3.79
Darbinieki	761
EBITDA	-5.7M 1.5M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+43.84% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 29. apr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-109M 891M
Iepriekšējā atvēršanas cena	19.69
Iepriekšējā slēgšanas cena	17.06

Ziņu noskaņojums

By Acuity

67%

33%

305 / 350 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

14.77 / 18.49 Atbalsts un pretestība

CareDx Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 20. marts 17:19 UTC

Galvenie ziņu notikumi

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

2026. g. 20. marts 16:56 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

2026. g. 20. marts 16:56 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

2026. g. 20. marts 16:45 UTC

Galvenie ziņu notikumi

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

2026. g. 20. marts 16:22 UTC

Galvenie ziņu notikumi

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

2026. g. 20. marts 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 20. marts 20:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2026. g. 20. marts 19:55 UTC

Tirgus saruna

Galvenie ziņu notikumi

Brent Crude Closes Out Volatile Week Higher -- Market Talk

2026. g. 20. marts 19:28 UTC

Tirgus saruna

Galvenie ziņu notikumi

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

2026. g. 20. marts 19:28 UTC

Iegādes, apvienošanās, pārņemšana

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026. g. 20. marts 18:39 UTC

Tirgus saruna

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

2026. g. 20. marts 18:31 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell Announces Pricing of Debt Tender Offers >HON

2026. g. 20. marts 18:19 UTC

Iegādes, apvienošanās, pārņemšana

Why Mayo and Soap No Longer Mix for Unilever -- Update

2026. g. 20. marts 18:15 UTC

Tirgus saruna

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

2026. g. 20. marts 17:57 UTC

Tirgus saruna

U.S. Oil Rig Count Inches Up -- Market Talk

2026. g. 20. marts 17:04 UTC

Galvenie ziņu notikumi

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

2026. g. 20. marts 16:20 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 20. marts 16:20 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2026. g. 20. marts 15:40 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

2026. g. 20. marts 15:30 UTC

Peļņas

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

2026. g. 20. marts 15:26 UTC

Tirgus saruna

Peļņas

Galvenie ziņu notikumi

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

2026. g. 20. marts 15:26 UTC

Iegādes, apvienošanās, pārņemšana

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

2026. g. 20. marts 15:25 UTC

Tirgus saruna

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

2026. g. 20. marts 15:19 UTC

Tirgus saruna

Galvenie ziņu notikumi

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

2026. g. 20. marts 14:58 UTC

Galvenie ziņu notikumi

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

2026. g. 20. marts 14:55 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Lower as Speculative Pullback Extends -- Market Talk

2026. g. 20. marts 14:54 UTC

Iegādes, apvienošanās, pārņemšana

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026. g. 20. marts 14:53 UTC

Iegādes, apvienošanās, pārņemšana

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

2026. g. 20. marts 14:46 UTC

Tirgus saruna

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

2026. g. 20. marts 14:45 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Salīdzinājums

Cenas izmaiņa

CareDx Inc Prognoze

Cenas mērķis

By TipRanks

43.84% augšup

Prognoze 12 mēnešiem

Vidējais 25 USD 43.84%

Augstākais 28 USD

Zemākais 21 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CareDx Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 6 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam CareDx Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

14.77 / 18.49Atbalsts un pretestība

The bullish and bearish events are balanced.

All events are bearish.

Bearish events outweigh bullish events.

Noskaņojums

By Acuity

305 / 350 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.